Trial Outcomes & Findings for Text Messaging for Supporting Quit Attempts (NCT NCT02571244)

NCT ID: NCT02571244

Last Updated: 2018-07-30

Results Overview

No smoking (even a puff) in the past 7 days at the first month follow up.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

66 participants

Primary outcome timeframe

Smoking abstinence at the first month after randomization

Results posted on

2018-07-30

Participant Flow

Participant milestones

Participant milestones
Measure
Motivational Interview Plus Text Message
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Overall Study
STARTED
44
22
Overall Study
COMPLETED
41
21
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Motivational Interview Plus Text Message
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Overall Study
Lost to Follow-up
0
1
Overall Study
Unable to reach out post discharge
3
0

Baseline Characteristics

Text Messaging for Supporting Quit Attempts

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Motivational Interview Plus Text Message
n=44 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping.
Control Arm
n=22 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Total
n=66 Participants
Total of all reporting groups
Age, Continuous
47.5 years
STANDARD_DEVIATION 12.7 • n=99 Participants
48.2 years
STANDARD_DEVIATION 8.9 • n=107 Participants
47.7 years
STANDARD_DEVIATION 11.5 • n=206 Participants
Sex: Female, Male
Female
20 Participants
n=99 Participants
12 Participants
n=107 Participants
32 Participants
n=206 Participants
Sex: Female, Male
Male
24 Participants
n=99 Participants
10 Participants
n=107 Participants
34 Participants
n=206 Participants
Race (NIH/OMB)
Race · American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Race · Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Race · Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Race · Black or African American
6 Participants
n=99 Participants
2 Participants
n=107 Participants
8 Participants
n=206 Participants
Race (NIH/OMB)
Race · White
27 Participants
n=99 Participants
17 Participants
n=107 Participants
44 Participants
n=206 Participants
Race (NIH/OMB)
Race · More than one race
11 Participants
n=99 Participants
3 Participants
n=107 Participants
14 Participants
n=206 Participants
Race (NIH/OMB)
Race · Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Smoking abstinence at the first month after randomization

Population: The primary analysis was intention-to-treat and involved all patients who were randomly assigned. The 7-day point prevalence abstinence rate was assessed as the first outcome (1-month assessment).

No smoking (even a puff) in the past 7 days at the first month follow up.

Outcome measures

Outcome measures
Measure
Motivational Interview Plus Text Message
n=44 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
n=22 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Self Reported Smoking Abstinence
11 Participants
2 Participants

SECONDARY outcome

Timeframe: At the third month after randomization

Population: It was included only patients that were able to be contacted for follow up (per protocol analysis).

The experimental group self reported daily cigarettes consumption at the third month after randomization with be compared to the control group.

Outcome measures

Outcome measures
Measure
Motivational Interview Plus Text Message
n=41 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
n=21 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Daily Cigarettes Consumption at 3 Months Among Continuing Smokers
12.9 Number of cigarettes smoked per day
Standard Deviation 5.2
14.6 Number of cigarettes smoked per day
Standard Deviation 5.5

SECONDARY outcome

Timeframe: at the third month after randomization

Population: It was included only patients that were able to be contacted for follow up (per protocol analysis).

self reported seek for specialized tobacco treatment after hospitalization

Outcome measures

Outcome measures
Measure
Motivational Interview Plus Text Message
n=41 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
n=21 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Self Reported Seek for Specialized Tobacco Treatment
0 Participants
1 Participants

SECONDARY outcome

Timeframe: Smoking abstinence at the third month after randomization

Population: The primary analysis was intention-to-treat and involved all patients who were randomly assigned. The 7-day point prevalence abstinence rate, at 3-month assessment, was assessed as a secondary outcome.

No smoking (even a puff) in the past 7 days at the third month after randomization.

Outcome measures

Outcome measures
Measure
Motivational Interview Plus Text Message
n=44 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
n=22 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Self Reported Smoking Abstinence
14 Participants
2 Participants

SECONDARY outcome

Timeframe: At third-month follow up

Population: Intention to Treat Analysis

Carbon Monoxide verified Smoking Abstinence at third-month follow up. Abstinence defined as Carbon Monoxide ≤ 6.

Outcome measures

Outcome measures
Measure
Motivational Interview Plus Text Message
n=44 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking, and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended treatment: Participants in this arm will receive a telephone counseling session using a motivational interviewing approach and fifteen or eight days of text messages. The timing, duration, and content of the counseling session will be consistent with guideline-based recommendations. Motivational Interview plus text message: After discharge the experimental group will receive extended care including a counseling session and text messages. The session will provide basic information about smoking and successful quitting. The counselor will use motivational interview techniques to build coping
Control Arm
n=22 Participants
Inside the hospital: All participants will receive the written materials. Patients with high tobacco dependence (Fagerstrom screening test score 5 or higher) will receive also Nicotine replacement therapy. The written materials provide information on, benefits of quitting smoking and strategies for a successful quit plan, including information on relapse prevention. Post discharge extended care: None
Carbon Monoxide Verified Smoking Abstinence
9 Participants
1 Participants

Adverse Events

Motivational Interview Plus Text Message

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Erica Cruvinel

Federal University of Juiz de Fora/Brazil

Phone: 55-32-99174-8855

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place